- Review
Sorafenib—Drug Delivery Strategies in Primary Liver Cancer
- Piotr Szyk,
- Beata Czarczynska-Goslinska,
- Marta Ziegler-Borowska,
- Igor Larrosa and
- Tomasz Goslinski
Current primary liver cancer therapies, including sorafenib and transarterial chemoembolization, face significant limitations due to chemoresistance caused by impaired drug uptake, altered metabolism, and other genetic modulations. These challenges c...

